AAAAAA

   
Results: 1-12 |
Results: 12
THE USE OF RABBIT INTESTINAL PERMEABILITY AS AN IN-VITRO ASSAY IN THESEARCH FOR ORALLY-ACTIVE GPIIB IIIA ANTAGONISTS/
Authors: SAMANEN JM LEE CP SMITH PL BONDINELL WE CALVO RR JAKAS DR NEWLANDER KA PARKER M UZINSKAS I YELLIN TO NICHOLS AJ
Citation: Jm. Samanen et al., THE USE OF RABBIT INTESTINAL PERMEABILITY AS AN IN-VITRO ASSAY IN THESEARCH FOR ORALLY-ACTIVE GPIIB IIIA ANTAGONISTS/, Advanced drug delivery reviews, 23(1-3), 1997, pp. 133-142
DISCOVERY OF POTENT NONPEPTIDE VITRONECTIN RECEPTOR (ALPHA(V)BETA(3))ANTAGONISTS
Authors: KEENAN RM MILLER WH KWON C ALI FE CALLAHAN JF CALVO RR HWANG SM KOPPLE KD PEISHOFF CE SAMANEN JM WONG AS YUAN CK HUFFMAN WF
Citation: Rm. Keenan et al., DISCOVERY OF POTENT NONPEPTIDE VITRONECTIN RECEPTOR (ALPHA(V)BETA(3))ANTAGONISTS, Journal of medicinal chemistry, 40(15), 1997, pp. 2289-2292
STRUCTURE-ACTIVITY-RELATIONSHIPS IN 3-OXO-1,4-BENZODIAZEPINE-2-ACETICACID GPIIB IIIA ANTAGONISTS - THE 2-BENZAZEPINE SERIES/
Authors: MILLER WH ALI FE BONDINELL WE CALLAHAN JF CALVO RR EGGLESTON DS HALTIWANGER RC HUFFMAN WF HWANG SM JAKAS DR KEENAN RM KOSTER PF KU TW KWON C NEWLANDER KA NICHOLS AJ PARKER MF SAMANEN JM SOUTHALL LS TAKATA DT UZINSKAS IN VALOCIK RE VASKOMOSER JA WONG AS YELLIN TO YUAN CCK
Citation: Wh. Miller et al., STRUCTURE-ACTIVITY-RELATIONSHIPS IN 3-OXO-1,4-BENZODIAZEPINE-2-ACETICACID GPIIB IIIA ANTAGONISTS - THE 2-BENZAZEPINE SERIES/, Bioorganic & medicinal chemistry letters, 6(21), 1996, pp. 2481-2486
POTENT, SELECTIVE, ORALLY-ACTIVE 3-OXO-1,4-BENZODIAZEPINE GPIIB IIIA INTEGRIN ANTAGONISTS/
Authors: SAMANEN JM ALI FE BARTON LS BONDINELL WE BURGESS JL CALLAHAN JF CALVO RR CHEN WT CHEN LC ERHARD K FEUERSTEIN G HEYS R HWANG SM JAKAS DR KEENAN RM KU TW KWON C LEE CP MILLER WH NEWLANDER KA NICHOLS A PARKER M PEISHOFF CE RHODES G ROSS S SHU A SIMPSON R TAKATA D YELLIN TO UZSINSKAS I VENSLAVSKY JW YUAN CK HUFFMAN WF
Citation: Jm. Samanen et al., POTENT, SELECTIVE, ORALLY-ACTIVE 3-OXO-1,4-BENZODIAZEPINE GPIIB IIIA INTEGRIN ANTAGONISTS/, Journal of medicinal chemistry, 39(25), 1996, pp. 4867-4870
ENANTIOSPECIFIC SYNTHESIS OF SB-214857, A POTENT, ORALLY-ACTIVE, NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONIST
Authors: MILLER WH KU TW ALI FE BONDINELL WE CALVO RR DAVIS LD ERHARD KF HALL LB HUFFMAN WF KEENAN RM KWON C NEWLANDER KA ROSS ST SAMANEN JM TAKATA DT YUAN CK
Citation: Wh. Miller et al., ENANTIOSPECIFIC SYNTHESIS OF SB-214857, A POTENT, ORALLY-ACTIVE, NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONIST, Tetrahedron letters, 36(52), 1995, pp. 9433-9436
POTENT NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONISTS WHICH PRESENT AN ALTERNATIVE PHARMACOPHORE
Authors: KU TW MILLER WH BONDINELL WE ERHARD KF KEENAN RM NICHOLS AJ PEISHOFF CE SAMANEN JM WONG AS HUFFMAN WF
Citation: Tw. Ku et al., POTENT NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONISTS WHICH PRESENT AN ALTERNATIVE PHARMACOPHORE, Journal of medicinal chemistry, 38(1), 1995, pp. 9-12
THE IN-VITRO PHARMACOLOGICAL PROFILE OF SK-AND-F-106760, A NOVEL GPIIB IIIA ANTAGONIST/
Authors: NICHOLS AJ VASKO JA VALOCIK RE KOPACIEWICZ LJ STORER BL ALI FE ROMOFF T CALVO R SAMANEN JM
Citation: Aj. Nichols et al., THE IN-VITRO PHARMACOLOGICAL PROFILE OF SK-AND-F-106760, A NOVEL GPIIB IIIA ANTAGONIST/, Thrombosis research, 75(2), 1994, pp. 143-156
THE IN-VIVO PHARMACOLOGICAL PROFILE OF THE NOVEL GLYCOPROTEIN-IIB IIIA ANTAGONIST, SK-AND-F-106760/
Authors: NICHOLS AJ VASKO JA KOSTER PF VALOCIK RE RHODES GR MILLERSTEIN C BOPPANA V SAMANEN JM
Citation: Aj. Nichols et al., THE IN-VIVO PHARMACOLOGICAL PROFILE OF THE NOVEL GLYCOPROTEIN-IIB IIIA ANTAGONIST, SK-AND-F-106760/, The Journal of pharmacology and experimental therapeutics, 270(2), 1994, pp. 614-621
CONFORMATIONALLY CONSTRAINED PEPTIDES AND SEMIPEPTIDES DERIVED FROM RGD AS POTENT INHIBITORS OF THE PLATELET FIBRINOGEN RECEPTOR AND PLATELET-AGGREGATION
Authors: ALI FE BENNETT DB CALVO RR ELLIOTT JD HWANG SM KU TW LAGO MA NICHOLS AJ ROMOFF TT SHAH DH VASKO JA WONG AS YELLIN TO YUAN CK SAMANEN JM
Citation: Fe. Ali et al., CONFORMATIONALLY CONSTRAINED PEPTIDES AND SEMIPEPTIDES DERIVED FROM RGD AS POTENT INHIBITORS OF THE PLATELET FIBRINOGEN RECEPTOR AND PLATELET-AGGREGATION, Journal of medicinal chemistry, 37(6), 1994, pp. 769-780
REFINEMENT OF A MOLECULAR-MODEL OF ANGIOTENSIN-II (AII) EMPLOYED IN THE DISCOVERY OF POTENT NONPEPTIDE ANTAGONISTS
Authors: SAMANEN JM PEISHOFF CE KEENAN RM WEINSTOCK J
Citation: Jm. Samanen et al., REFINEMENT OF A MOLECULAR-MODEL OF ANGIOTENSIN-II (AII) EMPLOYED IN THE DISCOVERY OF POTENT NONPEPTIDE ANTAGONISTS, Bioorganic & medicinal chemistry letters, 3(5), 1993, pp. 909-914
POTENT NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS .2. 1-(CARBOXYBENZYL)IMIDAZOLE-5-ACRYLIC ACIDS
Authors: KEENAN RM WEINSTOCK J FINKELSTEIN JA FRANZ RG GAITANOPOULOS DE GIRARD GR HILL DT MORGAN TM SAMANEN JM PEISHOFF CE TUCKER LM AIYAR N GRIFFIN E OHLSTEIN EH STACK EJ WEIDLEY EF EDWARDS RM
Citation: Rm. Keenan et al., POTENT NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS .2. 1-(CARBOXYBENZYL)IMIDAZOLE-5-ACRYLIC ACIDS, Journal of medicinal chemistry, 36(13), 1993, pp. 1880-1892
DIRECT DESIGN OF A POTENT NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONIST BASED ON THE STRUCTURE AND CONFORMATION OF A HIGHLY CONSTRAINED CYCLIC RGD PEPTIDE
Authors: KU TW ALI FE BARTON LS BEAN JW BONDINELL WE BURGESS JL CALLAHAN JF CALVO RR CHEN LC EGGLESTON DS GLEASON JG HUFFMAN WF HWANG SM JAKAS DR KARASH CB KEENAN RM KOPPLE KD MILLER WH NEWLANDER KA NICHOLS A PARKER MF PEISHOFF CE SAMANEN JM UZINSKAS I VENSLAVSKY JW
Citation: Tw. Ku et al., DIRECT DESIGN OF A POTENT NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONIST BASED ON THE STRUCTURE AND CONFORMATION OF A HIGHLY CONSTRAINED CYCLIC RGD PEPTIDE, Journal of the American Chemical Society, 115(19), 1993, pp. 8861-8862
Risultati: 1-12 |